Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?

To: Bosco who wrote (861)	4/7/2000 5:53:00 PM
From: Madharry	Read Replies (2) \| Respond to of 1298

I do not agree with you there Bosco. If Cell genesys ongoing business proves to be worthless your are still looking at an entity with about $240MM in cash and $360MM of ABGX stock. therefore if I attach no value to the current business I would expect CEGE to rise about 60% of the pace of the rise in ABGX stock. so if ABGX goes up 10% I would expect a 6% rise in the value of CEGE Stock. Unless you can tell me what you think CEGE' business is worth right now?